477 related articles for article (PubMed ID: 15582691)
61. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host.
Gao Y; Leary TP; Eskra L; Splitter GA
Vaccine; 1994 Feb; 12(2):145-52. PubMed ID: 8147097
[TBL] [Abstract][Full Text] [Related]
62. Characterization of B virus glycoprotein antibodies induced by DNA immunization.
Perelygina L; Patrusheva I; Zurkuhlen H; Hilliard JK
Arch Virol; 2002 Nov; 147(11):2057-73. PubMed ID: 12417944
[TBL] [Abstract][Full Text] [Related]
63. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.
van Drunen Littel-van den Hurk S; Van Donkersgoed J; Kowalski J; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
Vaccine; 1994 Nov; 12(14):1295-302. PubMed ID: 7856294
[TBL] [Abstract][Full Text] [Related]
64. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.
Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK
J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863
[TBL] [Abstract][Full Text] [Related]
65. Serologic response to Mannheimia haemolytica in calves concurrently inoculated with inactivated or modified-live preparations of M. haemolytica and viral combination vaccines containing modified-live bovine herpesvirus type 1.
Cortese VS; Seeger JT; Stokka GS; Hunsaker BD; Lardy GP; Weigel DJ; Brumbaugh GW
Am J Vet Res; 2011 Nov; 72(11):1541-9. PubMed ID: 22023134
[TBL] [Abstract][Full Text] [Related]
66. Intercellular trafficking of the major tegument protein VP22 of bovine herpesvirus-1 and its application to improve a DNA vaccine.
Zheng CF; Brownlie R; Huang DY; Babiuk LA; van Drunen Littel-van den Hurk S
Arch Virol; 2006 May; 151(5):985-93. PubMed ID: 16374718
[TBL] [Abstract][Full Text] [Related]
67. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
[TBL] [Abstract][Full Text] [Related]
68. Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.
Belknap EB; Walters LM; Kelling C; Ayers VK; Norris J; McMillen J; Hayhow C; Cochran M; Reddy DN; Wright J; Collins JK
Vaccine; 1999 May; 17(18):2297-305. PubMed ID: 10403598
[TBL] [Abstract][Full Text] [Related]
69. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein.
Mota J; Acosta M; Argotte R; Figueroa R; Méndez A; Ramos C
Vaccine; 2005 May; 23(26):3469-76. PubMed ID: 15837370
[TBL] [Abstract][Full Text] [Related]
70. Partial protection induced by a BHV-1 recombinant vaccine against challenge with BHV-5.
Spilki FR; Silva AD; Hübner S; Esteves PA; Franco AC; Driemeier D; Roehe PM
Ann N Y Acad Sci; 2004 Oct; 1026():247-50. PubMed ID: 15604501
[TBL] [Abstract][Full Text] [Related]
71. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
Shen S; Wang S; Britt WJ; Lu S
Vaccine; 2007 Apr; 25(17):3319-27. PubMed ID: 17287056
[TBL] [Abstract][Full Text] [Related]
72. Induction of Both Local Immune Response in Mice and Protection in a Rabbit Model by Intranasal Immunization with Modified Vaccinia Ankara Virus Expressing a Secreted Form of Bovine Herpesvirus 1 Glycoprotein D.
Del Medico Zajac MP; Zanetti FA; Esusy MS; Federico CR; Zabal O; Valera AR; Calamante G
Viral Immunol; 2017; 30(1):70-76. PubMed ID: 27809679
[TBL] [Abstract][Full Text] [Related]
73. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
[TBL] [Abstract][Full Text] [Related]
74. Generation by self re-fusion of bovine³ × murine² heterohybridomas secreting virus-neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD.
Levings RL; Stoll IR; Warg JV; Patterson PA; Hobbs LA; Kaeberle ML; Roth JA
Vet Immunol Immunopathol; 2014 May; 159(1-2):58-73. PubMed ID: 24629764
[TBL] [Abstract][Full Text] [Related]
75. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
76. Immunogenicity in mice of a cationic microparticle-adsorbed plasmid DNA encoding Japanese encephalitis virus envelope protein.
Kaur R; Rauthan M; Vrati S
Vaccine; 2004 Jul; 22(21-22):2776-82. PubMed ID: 15246611
[TBL] [Abstract][Full Text] [Related]
77. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
Tengvall S; Josefsson A; Holmgren J; Harandi AM
J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
[TBL] [Abstract][Full Text] [Related]
78. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.
Zakhartchouk AN; Pyne C; Mutwiri GK; Papp Z; Baca-Estrada ME; Griebel P; Babiuk LA; Tikoo SK
J Gen Virol; 1999 May; 80 ( Pt 5)():1263-1269. PubMed ID: 10355773
[TBL] [Abstract][Full Text] [Related]
79. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
[TBL] [Abstract][Full Text] [Related]
80. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
